vs
Encompass Health Corp（EHC）とPost Holdings, Inc.（POST）の財務データ比較。上の社名をクリックして会社を切り替えられます
Post Holdings, Inc.の直近四半期売上が大きい（$2.2B vs $1.5B、Encompass Health Corpの約1.4倍）。Encompass Health Corpの純利益率が高く（9.5% vs 4.5%、差は5.0%）。Post Holdings, Inc.の前年同期比売上増加率が高い（10.1% vs 9.9%）。Post Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$119.3M vs $116.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 4.3%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
Post Holdings, Inc.はアメリカの代表的な包装消費財食品メーカーで、主力事業にPost Consumer Brandsを有し、本社はミネソタ州レイクビルに所在します。同社が製造する各種食品は北米を中心に世界各国で販売され、多くの消費者に支持されています。
EHC vs POST — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $2.2B |
| 純利益 | $146.1M | $96.8M |
| 粗利率 | — | 29.4% |
| 営業利益率 | 16.7% | 11.0% |
| 純利益率 | 9.5% | 4.5% |
| 売上前年比 | 9.9% | 10.1% |
| 純利益前年比 | 20.8% | -14.6% |
| EPS（希薄化後） | $1.43 | $1.71 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $2.2B | ||
| Q3 25 | $1.5B | $2.2B | ||
| Q2 25 | $1.5B | $2.0B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.4B | $2.0B | ||
| Q3 24 | $1.4B | $2.0B | ||
| Q2 24 | $1.3B | $1.9B | ||
| Q1 24 | $1.3B | $2.0B |
| Q4 25 | $146.1M | $96.8M | ||
| Q3 25 | $126.5M | $51.0M | ||
| Q2 25 | $142.1M | $108.8M | ||
| Q1 25 | $151.5M | $62.6M | ||
| Q4 24 | $120.9M | $113.3M | ||
| Q3 24 | $108.2M | $81.6M | ||
| Q2 24 | $114.1M | $99.8M | ||
| Q1 24 | $112.5M | $97.2M |
| Q4 25 | — | 29.4% | ||
| Q3 25 | — | 26.8% | ||
| Q2 25 | — | 30.0% | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 30.1% | ||
| Q3 24 | — | 28.6% | ||
| Q2 24 | — | 29.6% | ||
| Q1 24 | — | 29.0% |
| Q4 25 | 16.7% | 11.0% | ||
| Q3 25 | 14.9% | 7.5% | ||
| Q2 25 | 16.2% | 11.8% | ||
| Q1 25 | 16.4% | 9.3% | ||
| Q4 24 | 14.3% | 10.8% | ||
| Q3 24 | 13.6% | 9.5% | ||
| Q2 24 | 14.3% | 10.4% | ||
| Q1 24 | 13.6% | 9.5% |
| Q4 25 | 9.5% | 4.5% | ||
| Q3 25 | 8.6% | 2.3% | ||
| Q2 25 | 9.7% | 5.5% | ||
| Q1 25 | 10.4% | 3.2% | ||
| Q4 24 | 8.6% | 5.7% | ||
| Q3 24 | 8.0% | 4.1% | ||
| Q2 24 | 8.8% | 5.1% | ||
| Q1 24 | 8.5% | 4.9% |
| Q4 25 | $1.43 | $1.71 | ||
| Q3 25 | $1.24 | $0.91 | ||
| Q2 25 | $1.39 | $1.79 | ||
| Q1 25 | $1.48 | $1.03 | ||
| Q4 24 | $1.18 | $1.78 | ||
| Q3 24 | $1.06 | $1.28 | ||
| Q2 24 | $1.12 | $1.53 | ||
| Q1 24 | $1.10 | $1.48 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $279.3M |
| 総負債低いほど良い | $2.4B | $7.5B |
| 株主資本純資産 | $2.4B | $3.5B |
| 総資産 | $7.1B | $13.0B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | 2.16× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $279.3M | ||
| Q3 25 | $48.7M | $176.7M | ||
| Q2 25 | $99.1M | $1.1B | ||
| Q1 25 | $95.8M | $617.6M | ||
| Q4 24 | $85.4M | $872.9M | ||
| Q3 24 | $147.8M | $787.4M | ||
| Q2 24 | $154.4M | $333.8M | ||
| Q1 24 | $134.4M | $333.4M |
| Q4 25 | $2.4B | $7.5B | ||
| Q3 25 | $2.4B | $7.4B | ||
| Q2 25 | $2.3B | $7.3B | ||
| Q1 25 | $2.3B | $6.9B | ||
| Q4 24 | $2.4B | $6.9B | ||
| Q3 24 | $2.3B | $6.8B | ||
| Q2 24 | $2.7B | $6.4B | ||
| Q1 24 | $2.7B | $6.4B |
| Q4 25 | $2.4B | $3.5B | ||
| Q3 25 | $2.4B | $3.8B | ||
| Q2 25 | $2.3B | $4.0B | ||
| Q1 25 | $2.2B | $3.8B | ||
| Q4 24 | $2.1B | $3.9B | ||
| Q3 24 | $2.0B | $4.1B | ||
| Q2 24 | $1.8B | $3.9B | ||
| Q1 24 | $1.7B | $4.0B |
| Q4 25 | $7.1B | $13.0B | ||
| Q3 25 | $6.9B | $13.5B | ||
| Q2 25 | $6.8B | $13.4B | ||
| Q1 25 | $6.6B | $12.8B | ||
| Q4 24 | $6.5B | $12.8B | ||
| Q3 24 | $6.5B | $12.9B | ||
| Q2 24 | $6.4B | $12.1B | ||
| Q1 24 | $6.2B | $12.2B |
| Q4 25 | 1.00× | 2.16× | ||
| Q3 25 | 1.01× | 1.98× | ||
| Q2 25 | 1.02× | 1.84× | ||
| Q1 25 | 1.08× | 1.81× | ||
| Q4 24 | 1.14× | 1.79× | ||
| Q3 24 | 1.20× | 1.67× | ||
| Q2 24 | 1.46× | 1.62× | ||
| Q1 24 | 1.54× | 1.61× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $235.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $119.3M |
| FCFマージンFCF / 売上 | 7.6% | 5.5% |
| 設備投資強度設備投資 / 売上 | 14.8% | 5.4% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 2.43× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $436.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $235.7M | ||
| Q3 25 | $270.8M | $301.3M | ||
| Q2 25 | $270.2M | $225.9M | ||
| Q1 25 | $288.6M | $160.7M | ||
| Q4 24 | $278.8M | $310.4M | ||
| Q3 24 | $267.8M | $235.4M | ||
| Q2 24 | $217.4M | $272.3M | ||
| Q1 24 | $238.8M | $249.6M |
| Q4 25 | $116.7M | $119.3M | ||
| Q3 25 | $83.7M | $151.6M | ||
| Q2 25 | $113.3M | $94.9M | ||
| Q1 25 | $125.5M | $70.2M | ||
| Q4 24 | $80.1M | $171.4M | ||
| Q3 24 | $120.3M | $96.2M | ||
| Q2 24 | $60.5M | $161.5M | ||
| Q1 24 | $99.4M | $150.9M |
| Q4 25 | 7.6% | 5.5% | ||
| Q3 25 | 5.7% | 6.7% | ||
| Q2 25 | 7.8% | 4.8% | ||
| Q1 25 | 8.6% | 3.6% | ||
| Q4 24 | 5.7% | 8.7% | ||
| Q3 24 | 8.9% | 4.8% | ||
| Q2 24 | 4.6% | 8.3% | ||
| Q1 24 | 7.6% | 7.5% |
| Q4 25 | 14.8% | 5.4% | ||
| Q3 25 | 12.7% | 6.7% | ||
| Q2 25 | 10.8% | 6.6% | ||
| Q1 25 | 11.2% | 4.6% | ||
| Q4 24 | 14.1% | 7.0% | ||
| Q3 24 | 10.9% | 6.9% | ||
| Q2 24 | 12.1% | 5.7% | ||
| Q1 24 | 10.6% | 4.9% |
| Q4 25 | 2.37× | 2.43× | ||
| Q3 25 | 2.14× | 5.91× | ||
| Q2 25 | 1.90× | 2.08× | ||
| Q1 25 | 1.90× | 2.57× | ||
| Q4 24 | 2.31× | 2.74× | ||
| Q3 24 | 2.48× | 2.88× | ||
| Q2 24 | 1.91× | 2.73× | ||
| Q1 24 | 2.12× | 2.57× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
POST
| Post Consumer Brands Segment | $1.1B | 51% |
| Pet Food | $360.4M | 17% |
| Side Dishes | $221.5M | 10% |
| Weetabix | $137.9M | 6% |
| Other | $122.1M | 6% |
| Nut Butters | $105.8M | 5% |
| Sausage | $53.1M | 2% |
| Cheeseand Dairy | $41.3M | 2% |
| Protein Based Shakes | $29.3M | 1% |
| Bell Ring | $18.1M | 1% |
